What Does Farxiga Look Like: Visual ID and Key Details
Farxiga (dapagliflozin) is an oral diabetes and chronic kidney disease medication produced by AstraZeneca. This guide describes the most common visual features you will see at the pharmacy: standard tablet appearance, blister packaging, color coding by strength, and imprint markings used by manufacturers. Understanding these characteristics can help distinguish Farxiga from look‑alike medicines and support safe use. This information reflects widely observed, evergreen traits rather than one‑time promotions or short‑term offers.
Tablet Visual Profile
Shape, Size, and Imprint
Farxiga tablets are typically round to slightly oval with a flat face and a beveled edge that makes them easy to handle. The exact diameter varies slightly by strength and manufacturer, but most units fall in the mid‑size range for oral tablets. Common imprint codes include a stylized "DA" or the dose number, positioned on one flat side. These imprints help pharmacists and people taking the medicine quickly confirm the product and strength.
Color Variations by Strength
Different strengths of Farxiga are often distinguished by tablet color, which supports fast visual checks. While colors can vary by country and by the specific manufacturing line, the following patterns are commonly reported and remain stable over time.
| Strength | Typical Tablet Color | Imprint Examples | Source Type |
|---|---|---|---|
| 5 mg | White to off‑white | Line or "5" | Manufacturer labeling |
| 10 mg | Pale blue or light blue | Stylized "DA" or "10" | Manufacturer labeling |
Packaging and Blister Appearance
Blister Pack Layout
Farxiga is commonly sold in rectangular blister cards with clearly defined pockets (blisters) that hold one tablet each. Each blister is labeled with the strength, lot number, and expiration date in printed, high‑contrast text. The backing card is usually a light color, such as white or light gray, to make the printing easy to read. Some regions use push‑through foil strips that release one tablet at a time; others use a simple fold‑open card with individual pockets.
Carton and Outer Packaging
The primary carton is typically rectangular, rigid, and printed with the Farxiga brand name, a stylized leaf or flow motif, and essential safety information. Prominent labeling includes the active ingredient (dapagliflozin), strength, and large expiry text. Cartons also carry storage instructions, such as keeping the pack in a cool, dry place, and may include a scannable barcode or QR area that links to product information. Generic versions usually display the drug name in standard text and may adopt different but regulation‑compliant color schemes for each strength.
How to Visually Confirm You Have Farxiga
- Check the imprint: Look for a stylized "DA," the dose number, or a similar code stamped on the tablet.
- Match the color: Compare the tablet color to the expected shade for your prescribed strength, noting that palettes can differ by region.
- Inspect the packaging: Verify that the blister or bottle label lists "dapagliflozin" or "Farxiga," the correct strength, lot number, and expiration date.
- Review the carton: Confirm storage guidance and that the outer carton matches the medication you are taking.
Generic Versions and Visual Differences
Many countries allow authorized generic versions of dapagliflozin, which must meet the same safety and quality standards as the reference product. Generics typically show the drug name "dapagliflozin" and the strength on a plain tablet, often with simpler packaging and a lower cost mark. Colors and imprints can differ from the AstraZeneca reference brand, which is why confirming the exact imprint and, when uncertain, consulting a pharmacist is recommended.
Safety and Confirmation Steps
If you are unsure whether a pill or pack is Farxiga, the safest approach is to bring the medication to a pharmacist for visual and label verification. Pharmacists can compare imprints, packaging format, and color coding against reference samples. Do not rely solely on color, as lighting and manufacturing batches can affect appearance. Always check that the imprint, strength, and expiration date match your prescription information.